Brief: Arrivent Biopharma Enters Open Market Sale Agreement For Offer And Sell Common Stock Up To $250 Million - SEC Filing
11/05/2026 23:12
May 11 (Reuters) - Arrivent Biopharma Inc AVBP.O: ARRIVENT BIOPHARMA INC - ENTERS OPEN MARKET SALE AGREEMENT FOR OFFER AND SELL COMMON STOCK UP TO $250 MILLION - SEC FILING Source text: [ID:n0001104659-26-058700] Further company coverage: AVBP.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on ArriVent BioPharma
See all newsBrief: Arrivent Announces First Patient Dosed With Novel Tetravalent Muc16/Napi2b Dual Target Adc, Arr-002
US RESEARCH ROUNDUP-Allstate, Caribou Biosciences, Zscaler
U.S. STOCKS ON THE MOVE-Becton Dickinson, Constellation Energy, Marvell
U.S. STOCKS ON THE MOVE-Constellation Energy, AMD
ArriVent falls after lung cancer drug misses late-stage trial goal